166 related articles for article (PubMed ID: 8396277)
1. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice.
Gale GR; Smith AB; Jones MM; Singh PK
Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277
[TBL] [Abstract][Full Text] [Related]
2. Decreasing 203Hg retention by intraperitoneal treatment with monoalkyl esters of meso-2,3-dimercaptosuccinic acid in rats.
Kostial K; Blanusa M; Simonović I; Jones MM; Singh PK
J Appl Toxicol; 1993; 13(5):321-5. PubMed ID: 8258628
[TBL] [Abstract][Full Text] [Related]
3. Mobilization of lead in mice by administration of monoalkyl esters of meso-2,3-dimercaptosuccinic acid.
Walker EM; Stone A; Milligan LB; Gale GR; Atkins LM; Smith AB; Jones MM; Singh PK; Basinger MA
Toxicology; 1992 Nov; 76(1):79-87. PubMed ID: 1335621
[TBL] [Abstract][Full Text] [Related]
4. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
5. Antidotal efficacy of newly synthesized dimercaptosuccinic acid (DMSA) monoesters in experimental arsenic poisoning in mice.
Kreppel H; Reichl FX; Kleine A; Szinicz L; Singh PK; Jones MM
Fundam Appl Toxicol; 1995 Jul; 26(2):239-45. PubMed ID: 7589912
[TBL] [Abstract][Full Text] [Related]
6. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
[TBL] [Abstract][Full Text] [Related]
7. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
Kostial K; Blanusa M; Piasek M; Simonović I; Jones MM; Singh PK
Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694
[TBL] [Abstract][Full Text] [Related]
8. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review.
Muran PJ
Altern Ther Health Med; 2006; 12(3):70-5. PubMed ID: 16708769
[TBL] [Abstract][Full Text] [Related]
9. Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration.
Kostial K; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
J Appl Toxicol; 1995; 15(3):201-6. PubMed ID: 7560740
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid.
Bridges CC; Joshee L; Zalups RK
J Pharmacol Exp Ther; 2008 Jan; 324(1):383-90. PubMed ID: 17940195
[TBL] [Abstract][Full Text] [Related]
11. Human studies with the chelating agents, DMPS and DMSA.
Aposhian HV; Maiorino RM; Rivera M; Bruce DC; Dart RC; Hurlbut KM; Levine DJ; Zheng W; Fernando Q; Carter D
J Toxicol Clin Toxicol; 1992; 30(4):505-28. PubMed ID: 1331491
[TBL] [Abstract][Full Text] [Related]
12. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
Kostial K; Kargacin B; Blanusa M; Piasek M; Jones MM; Singh PK
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
[TBL] [Abstract][Full Text] [Related]
13. MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury.
Bridges CC; Joshee L; Zalups RK
Toxicol Sci; 2008 Sep; 105(1):211-20. PubMed ID: 18511429
[TBL] [Abstract][Full Text] [Related]
14. Neither DMPS nor DMSA is effective in quantitative elimination of elemental mercury after intentional IV injection.
Eyer F; Felgenhauer N; Pfab R; Drasch G; Zilker T
Clin Toxicol (Phila); 2006; 44(4):395-7. PubMed ID: 16809143
[TBL] [Abstract][Full Text] [Related]
15. Cadmium mobilization in vivo by intraperitoneal or oral administration of monoalkyl esters of meso-2,3-dimercaptosuccinic acid in the mouse.
Jones MM; Singh PK; Gale GR; Smith AB; Atkins LM
Pharmacol Toxicol; 1992 May; 70(5 Pt 1):336-43. PubMed ID: 1319053
[TBL] [Abstract][Full Text] [Related]
16. Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.
Zalups RK; Bridges CC
Chem Res Toxicol; 2012 Sep; 25(9):1825-38. PubMed ID: 22667351
[TBL] [Abstract][Full Text] [Related]
17. 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
Nogueira CW; Soares FA; Nascimento PC; Muller D; Rocha JB
Toxicology; 2003 Mar; 184(2-3):85-95. PubMed ID: 12499112
[TBL] [Abstract][Full Text] [Related]
18. Effect of DMPS and DMSA on the placental and fetal disposition of methylmercury.
Bridges CC; Joshee L; Zalups RK
Placenta; 2009 Sep; 30(9):800-5. PubMed ID: 19615742
[TBL] [Abstract][Full Text] [Related]
19. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
[TBL] [Abstract][Full Text] [Related]
20. [Effect of dimercaptosuccinic acid per os on distribution and excretion of 210Pb and 203Hg in mice].
Liang YY; Zhang JS; Tao ZQ; Yan XM; Xu XH; Chen ZJ
Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):379-82. PubMed ID: 7801787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]